Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease

2021 ◽  
Author(s):  
Tingfeng Wu ◽  
Junzhao Ye ◽  
Xiaorong Gong ◽  
Xin Li ◽  
Congxiang Shao ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Liver Disease ◽  
Risk Stratification ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Nonalcoholic Fatty Liver ◽  
Liver Parameters

scholarly journals Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease

2017 ◽  
Vol 153 (5) ◽  
pp. 1260-1272.e3 ◽  
Author(s):  
Lisa B. VanWagner ◽  
Hongyan Ning ◽  
Norrina B. Allen ◽  
Veeral Ajmera ◽  
Cora E. Lewis ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Liver Disease ◽  
Alcohol Use ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Nonalcoholic Fatty Liver

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms

2021 ◽  
Author(s):  
Søren Møller ◽  
Nina Kimer ◽  
Thit Kronborg ◽  
Josephine Grandt ◽  
Jens Dahlgaard Hove ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Liver Disease ◽  
Fatty Liver ◽  
Nonalcoholic Fatty Liver Disease ◽  
Fatty Liver Disease ◽  
Severe Form ◽  
Nonalcoholic Fatty Liver ◽  
The Metabolic Syndrome ◽  
Increased Risk ◽  
Near Future

AbstractNonalcoholic fatty liver disease (NAFLD) denotes a condition with excess fat in the liver. The prevalence of NAFLD is increasing, averaging > 25% of the Western population. In 25% of the patients, NAFLD progresses to its more severe form: nonalcoholic steatohepatitis and >25% of these progress to cirrhosis following activation of inflammatory and fibrotic processes. NAFLD is associated with obesity, type 2 diabetes, and the metabolic syndrome and represents a considerable and increasing health burden. In the near future, NAFLD cirrhosis is expected to be the most common cause for liver transplantation. NAFLD patients have an increased risk of developing cardiovascular disease as well as liver-related morbidity. In addition, hepatic steatosis itself appears to represent an independent cardiovascular risk factor. In the present review, we provide an overview of the overlapping mechanisms and prevalence of NAFLD and cardiovascular disease.

Sign in / Sign up

Export Citation Format

Share Document